Opkit Rolls Out Back-of-Office Generative AI Call Center for Medical Practices With a Human-in-the-Loop Model

August 7, 2024 7:00 AM

Opkit, a generative AI call center for the healthcare industry, announces its HIPAA-compliant, AI-powered software platform that automates back office phone calls for medical clinics. The platform manages outbound calls to payers for insurance verification, claims, and prior authorization, as well as calls to pharmacies for prescription checks, and calls to collect medical records. Opkit's AI solution is supported by a human-in-the-loop to...

Read more

LPW Training Services Named 2024 Best Company for Women to Work

August 7, 2024 7:00 AM

Women's Choice Award® Names LPW Training Services a 2024 Best Companies to Work for WomenSOMERVILLE, NJ / ACCESSWIRE / August 7, 2024 / LPW Training Services was recognized with three awards as a 2024 Best Companies to Work for Women, Inclusion, and Millennials. The Women's Choice Award is the only distinction that identifies the nation's best companies to work for based on robust criteria. "As a minority and women-owned company, LPW values...

Read more

Interactive Wound Dressing Market Is Expected to Reach USD 9.0 Billion by 2034 and Grow at a Compound Annual Growth Rate of 5.6% | FMI Inc.

August 7, 2024 5:00 AM

According to Future Market Insights (FMI), the global interactive wound dressing market is expected to grow from USD 5.2 billion in 2024 to USD 9.0 billion by 2034. By 2034, the market is projected to surge at a 5.6% CAGR. Rising long-term injuries, a growing senior citizen base, technological advancements in dressings, and increased consumer awareness are projected to fuel the market. The United Nations predicts that the global senior...

Read more

LICORbio and Bioz Collaborate to Elevate Scientific Insights With Advanced Publication Data Integration

August 7, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / August 7, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is excited to announce its collaboration with LICORbio, a leading provider of innovative solutions for life science research in both the instrument and reagent space. LICORbio's dedication to providing high-quality products across diverse scientific fields integrates seamlessly with Bioz's goal of improving research outcomes through data-driven...

Read more

New Results from AlzeCure's Pain Project TrkA-NAM Presented at the Pain Conference IASP 2024

August 7, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / August 07, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its presentation about the preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions, which is presented at the IASP 2024 World...

Read more

NHI Announces Third Quarter 2024 Dividend

August 6, 2024 4:15 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.90 per common share on November 1, 2024 to stockholders of record as of September 27, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven...

Read more

NHI Issues Investor Update

August 6, 2024 4:10 PM

MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and...

Read more

NHI Announces Second Quarter 2024 Results

August 6, 2024 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended June 30, 2024 was $0.81 compared to $0.92 during the same period in the prior year. Net income attributable to common stockholders per diluted common share for the six months ended June 30, 2024...

Read more

Rymedi Partners with Incora Health

August 6, 2024 11:45 AM

GREENVILLE, SC / ACCESSWIRE / August 6, 2024 / Rymedi and Incora Health announce their strategic partnership aimed at improving women's health. The Incora Health Earring, designed to monitor women's whole health through their unique menstrual cycles, will leverage Rymedi's blockchain-enabled patient and population health data platform to serve as a comprehensive digital patient and results management tool. Rymedi's patented technology separates...

Read more

VivaWell and Keyzell Holding Announce Strategic Global Cooperation to Develop Innovative AI Health Solutions

August 6, 2024 9:10 AM

MEXICO CITY, MEXICO / ACCESSWIRE / August 6, 2024 / VivaWell, the pioneering healthtech transforming healthcare in Mexico and Argentina, proudly announces a strategic global cooperation agreement with Keyzell Holding, the biotech leader recognized for its groundbreaking advancements in precision medicine that enhance patient quality of life and save lives. This agreement marks the beginning of a close collaboration between both companies, aimed...

Read more

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

August 6, 2024 9:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the full year ended December 31, 2023.Full Year 2023 Financial HighlightsIncome Statement:Revenue...

Read more

Biopharmaceutical Contract Manufacturing Market Is Expected to Reach USD 25.1 Billion by 2034 And Grow at A CAGR of 8.8% | Future Market Insights Inc.

August 6, 2024 8:30 AM

The biopharmaceutical contract manufacturing market is expected to be valued at USD 10.7 billion in 2024. The market is projected to progress at a CAGR of 8.8% and reach a market value of USD 25.1 billion by 2034. The market is witnessing a surge in demand for various reasons. Biologics are complex molecules that require specialized expertise for their manufacture. Therefore, pharmaceutical companies prefer outsourcing their manufacturing...

Read more

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

August 6, 2024 8:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that following the wind down of operations, it has entered into a definitive agreement to divest its Consumer Health (a/k/a Innovus Pharmaceuticals) business to a private, e-commerce focused company. The divested business encompasses the established e-commerce platform, certain inventory and...

Read more

Sunshine Biopharma Announces Reverse Stock Split

August 6, 2024 8:00 AM

Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, announced today a one for twenty reverse split of its common stock, effective at market open on August 8, 2024. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for...

Read more

Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology

August 6, 2024 8:00 AM

FORT MILL, SC / ACCESSWIRE / August 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today the publication of its first LockeT study in the Journal of Cardiovascular Electrophysiology. The study titled, Feasibility, safety and efficacy of a novel external compression vascular closure device: The LockeT Study, was made available online on August 5, 2024.The study demonstrates the...

Read more

Ainos Concludes Growth Financing From Lind Partners

August 6, 2024 7:30 AM

Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose interferon therapeutics ("VELDONA"), today announced that the Company has prepaid its remaining convertible note financing (the "Note") with Lind Global Fund II LP, an institutional investment fund managed by The Lind Partners (together the "Investor"), through conversions of the...

Read more

Acreage Commences Non-Medical Cannabis Sales in Ohio

August 6, 2024 7:00 AM

Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U)(CSE:ACRG.B.U)(OTCQX:ACRHF)(OTCQX:ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today announced the launch of non-medical cannabis sales in Ohio. Beginning today, non-medical consumers in Ohio who are 21+ can purchase cannabis products from The Botanist locations in Akron, Canton, Cleveland, Wickliffe, and...

Read more

Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update

August 6, 2024 7:00 AM

Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the second quarter ended June 30, 2024, and provided a corporate update."During the second quarter of 2024 our team made tremendous strides in the late-stage clinical development of rusfertide and also in leveraging our proprietary discovery platform for early-stage, but highly differentiated, oral peptides-based discovery programs," said...

Read more

Ainos Reports Second Quarter 2024 Financial Results

August 5, 2024 4:15 PM

Enrolling first subject for FCGS clinical study marks a solid start in shifting animal health emphasis to drug developmentsRobust financial runway for over 12 months following the prepayment of a senior secured convertible noteSAN DIEGO, CA / ACCESSWIRE / August 5, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose...

Read more

Houston Medical Waste Disposal Company Tackles Piercing Surge in Needlestick Injuries With Essential Guide

August 5, 2024 2:30 PM

The CDC has reported an estimated 385,000 incidents of needlestick and sharps-related injuries among healthcare workers annually in the U.S.HOUSTON, TX / ACCESSWIRE / August 5, 2024 / With the number of needlestick injuries reaching concerning levels, BioMedical Waste Solutions, a prominent national provider of medical waste disposal services headquartered in Houston, TX, is proactively working to educate the public on the dangers of improperly...

Read more